Five Prime proposes IPO

Five Prime Therapeutics Inc., South San Francisco, Calif. Business: Cancer, Autoimmune, Inflammation Date announced: 7/26/13 Type: IPO To be raised: Up to $60 million Shares: TBD Price: TBD Underwrite...